Category : Clinical Research, Pharma & Healthcare Financing

Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel disease-agnostic therapies for patients with photoreceptor loss and vision impairment from retinal degeneration,...

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) (“Scinai”, or the “Company”), a biopharmaceutical company focused on developing novel and innovative biological drug candidates for the treatment of inflammation...

Baxdrostat 2mg lowered systolic blood pressure by 15.7 mmHg (9.8 mmHg placebo-adjusted) from baseline, and was generally well tolerated with no unanticipated safety findings Full...

Results from the Phase 3 VICTOR trial and a pooled analysis of the VICTOR and VICTORIA trials were presented today at the ESC Congress 2025...

Findings from COLLIGO-HCM reinforce Camzyos’ efficacy and safety profile in reducing left ventricular outflow tract (LVOT) obstruction and improving symptom burden in a racially diverse,...

The unique amniotic membrane allograft aids in the covering and protection of wounds BioLab Holdings, Inc. announced today that five of its amniotic membrane allograft products...

Foresee Pharmaceuticals (6576.TWO), (“Foresee”) announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for CAMCEVI ETM (leuprolide...

Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA)...

Final analysis of RATIONALE-315 demonstrates clear overall survival benefit in perioperative setting in resectable non-small cell lung cancer Broad EU label with nine approved indications...

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, and University College London (UCL) today announced that data published online in Cell show that the Decipher Prostate Genomic...

Phase 2a trial designed to investigate the safety and preliminary analgesic efficacy of Trichomylin® softgel capsules ZYUS Life Sciences Corporation (the “Company”) (TSXV: ZYUS), a...

PackGene Biotech, a global contract research organization (CRO) and contract development and manufacturing organization (CDMO) leader in adeno-associated viral (AAV) vector technologies, and Children’s Medical Research...

– DAWNZERA demonstrated significant and sustained HAE attack rate reduction and long-term disease control – – Offers longest dosing option for HAE, with dosing every 4 or 8...